Can amiodarone cause hyperthyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Amiodarone Increase Thyroid Function (Cause Hyperthyroidism)?

Yes, amiodarone can cause hyperthyroidism, occurring in approximately 2-10% of patients, with the incidence varying based on geographic iodine intake. 1

Understanding Amiodarone-Induced Thyrotoxicosis

Amiodarone causes thyroid dysfunction through two distinct mechanisms due to its extremely high iodine content (37% by molecular weight) 2:

Two Types of Amiodarone-Induced Thyrotoxicosis (AIT)

Type 1 AIT - Iodine-induced hyperthyroidism 2:

  • Occurs in patients with pre-existing thyroid disease (nodular goiter, latent Graves' disease, thyroid autonomy)
  • Results from excess iodine triggering hormone synthesis in abnormal thyroid tissue
  • More common in iodine-deficient regions (up to 10% incidence) 2
  • Shows increased vascular flow on color-flow Doppler ultrasound

Type 2 AIT - Destructive thyroiditis 2:

  • Direct toxic effect of amiodarone on thyroid cells
  • Causes release of preformed thyroid hormones from damaged tissue
  • Occurs in structurally normal thyroid glands
  • No increased vascularity on Doppler ultrasound
  • More common in iodine-sufficient areas (up to 6% incidence) 2

Mixed forms exist and are not always distinguishable, with some patients showing features of both mechanisms 2, 3.

Clinical Significance and Mortality Risk

Amiodarone-induced hyperthyroidism poses greater danger than hypothyroidism because it can cause 1:

  • Thyrotoxicosis with life-threatening cardiac complications
  • Arrhythmia breakthrough or aggravation
  • Death - there are documented fatalities associated with amiodarone-induced thyrotoxicosis 1

Monitoring Requirements

Monitor thyroid function tests before treatment, at 1 and 3 months after initiation, then every 3-6 months thereafter 2. This is critical because recent data shows the cumulative 5-year incidence of any thyroid dysfunction approaches 38.5%, with the highest yearly incidence of hyperthyroidism (9.8%) occurring during the third treatment year 4.

Diagnostic Approach When Hyperthyroidism Develops

If any new arrhythmias appear, immediately consider hyperthyroidism 1. Confirm with:

  • Elevated serum T3 and T4
  • Suppressed TSH (using sensitive assay)
  • Flat TSH response to TRH (confirmatory in equivocal cases) 1

Distinguish Type 1 from Type 2 2:

  • Color-flow Doppler ultrasound (increased flow suggests Type 1)
  • Radioactive iodine uptake if measurable (occasionally positive in Type 1, particularly in iodine-deficient regions; absent in Type 2)
  • Note: Serum interleukin-6 levels are NOT reliable for differentiation 2

Treatment Algorithm

Decision on Amiodarone Continuation

Determine whether amiodarone can be safely discontinued in consultation with cardiology 2. Consider that:

  • Amiodarone may be the only effective antiarrhythmic available
  • The drug persists for months due to fat solubility
  • Amiodarone has T3-antagonistic cardiac effects, so withdrawal may paradoxically worsen cardiac thyrotoxicosis 2
  • Type 2 AIT typically resolves even with continued amiodarone 2

Medical Management Based on Type

For Type 1 AIT: 2

  • Methimazole 40 mg daily
  • Consider potassium perchlorate if available (not in United States)
  • Beta-blockers for symptom control

For Type 2 AIT: 2

  • Prednisone 40 mg daily
  • Improvement typically within 1 week to several weeks
  • Beta-blockers for symptom control

For mixed/indeterminate forms or treatment failures: 2

  • Combined therapy with both methimazole AND prednisone
  • Continue until stabilization, then taper individually

Surgical Management

Thyroidectomy is indicated when 2:

  • Aggressive medical therapy with methimazole and corticosteroids fails
  • Amiodarone cannot be discontinued due to refractory arrhythmia
  • Rapid restoration of euthyroidism is essential

Critical caveat: Thyroidectomy can precipitate thyroid storm in this setting, requiring meticulous surgical and anesthetic planning 1.

Important Clinical Pitfalls

  • Radioactive iodine therapy is contraindicated due to low uptake from iodine saturation 1
  • Antithyroid drugs act slowly in AIT due to large stores of preformed thyroid hormones 1
  • Thyroid dysfunction can persist for weeks to months after amiodarone discontinuation due to its long half-life 1
  • Recent evidence suggests continuing amiodarone during treatment delays restoration of euthyroidism and increases recurrence risk 3
  • Hypothyroidism may follow hyperthyroidism treatment (transient period) 1
  • Thyroid nodules and thyroid cancer have been reported in postmarketing surveillance 1

The high cumulative incidence (nearly 40% at 5 years) 4 and potential for fatal complications 1 make vigilant monitoring and aggressive early treatment of amiodarone-induced hyperthyroidism essential for patient safety.

References

Guideline

hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2011

Research

Amiodarone and the thyroid: a 2012 update.

Journal of endocrinological investigation, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.